Advising a Chief Medical Officer
Challenge
An oncology-focused biopharma company needed support to develop a pipeline of kinase inhibitors in early- and late-stage development.
Solution
Our oncologist advised the Chief Medical Officer, helped the life-cycle management team plan for supplemental indications, contributed to protocol development and arranged meetings with key opinion leaders to discuss ideas for investigator-sponsored studies.
Related Case Studies
Explore similar engagements and see how we've helped other clients achieve their goals.
Gene therapy preclinical, CMC, and regulatory strategy
Challenge: An early-stage biotechnology startup company reached out to Alacrita for critical support of its two lead AAV-delivered gene therapy programs. As a virtual company, the...
Interim chief medical officer for antiviral drug company
Challenge A European company developing novel antiviral drugs urgently needed an experienced pharmaceutical physician to work as an interim CMO, as the predecessor was about to...
Assessing a new inhalation device and assisting with partnering
Challenge: A medical device company has developed a nebulizer system for pulmonary delivery that can produce droplets below 1.5µm diameter. Initial clinical evaluations of...
Clinical and regulatory support for respiratory delivery specialist
Challenge: A respiratory delivery specialist company was looking at established drugs to assess the attractiveness and risks of developing inhaled or intranasal formulations of...
Interested in Learning More?
Contact us to discuss how we can support your project with similar expertise.